9IA4 | pdb_00009ia4

Bc8.108 Fab


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.36 Å
  • R-Value Free: 
    0.280 (Depositor), 0.280 (DCC) 
  • R-Value Work: 
    0.218 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 
    0.221 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9IA4

This is version 1.0 of the entry. See complete history

Literature

In vivo efficacy of human anti-preS2 HBV neutralizing antibodies

Beretta, M.Haouz, A.Mechaly, A.E.Caillet-Saguy, C.Planchais, C.Szerman, N.Aronthippaitoon, Y.Ungeheuer, M.-N.Pol, S.Gaudy-graffin, C.Sureau, C.Bourgine, M.Mouquet, H.

To be published.

Macromolecule Content 

  • Total Structure Weight: 47.62 kDa 
  • Atom Count: 3,367 
  • Modeled Residue Count: 434 
  • Deposited Residue Count: 443 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Heavy chain215Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Light chain228Homo sapiensMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.36 Å
  • R-Value Free:  0.280 (Depositor), 0.280 (DCC) 
  • R-Value Work:  0.218 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 0.221 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 94.38α = 90
b = 146.16β = 90
c = 84.72γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Pasteur InstituteFrance--

Revision History  (Full details and data files)

  • Version 1.0: 2025-11-26
    Type: Initial release